Squarepoint’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
Squarepoint's LABU Position: Q4 2025 in Review
Squarepoint sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2025, closing a stake of 73,394 shares — an estimated $10.1M sold.
Squarepoint first reported a position in LABU in Q4 2021 and held it in 13 quarters. The position peaked at $9.17M in Q2 2025. 40 funds tracked by Wall St. Rank hold LABU as of Q4 2025.
- Squarepoint reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2025 after selling out during the quarter.
- Squarepoint sold 73,394 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2025, an estimated $10.1M.
- Squarepoint first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2021 and held it in 13 quarters.
- Squarepoint's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.17M in Q2 2025.
- 40 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2025.
Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.